News · Longevity & Aging
Blood aging clocks matched, but didn't beat, lifestyle questions
A Nature Aging study of 17,473 Europeans found protein-based aging clocks predicted death and disease well, then noted they did no better than asking about smoking, drinking and exercise.
Based on a peer-reviewed cohort study in Nature Aging
- Researchers analyzed 17,473 participants in the European Prospective Investigation into Cancer and Nutrition, with up to 28 years of follow-up, publishing in Nature Aging.
- Findings were replicated in a second cohort, the UK's Whitehall II study.
- Plasma proteins were used to build aging clocks, including organ-specific ones, producing an 'age gap' score for how much older or younger someone looks biologically.
- A higher global age gap was associated with smoking, alcohol consumption and physical inactivity.
- It also predicted higher risk of death, cardiovascular disease, dementia, and cancers of the liver, upper aero-digestive tract, lung and kidney.
- Organ-specific clocks did better for the matching organ: lung, kidney and stomach cancers tracked more strongly with their own organ's age gap.
- The deflating result: predictive performance for mortality was comparable to that of classical lifestyle risk factors.
Biological age tests have become a consumer product, sold on the promise that your blood knows something your birthday does not. A study in Nature Aging tested the best research version of that promise across 17,473 people, and delivered a result the industry will not enjoy quoting.
The clocks worked. But predictive performance of proteomic clocks for mortality was comparable to that of classical lifestyle risk factors: about as good as asking whether someone smokes.
What the clocks are
The premise is reasonable enough. Assessment of biological aging using proteomic clocks may enhance risk prediction and elucidate the molecular links between aging and chronic diseases.
The method reads thousands of proteins circulating in plasma and trains a model to predict chronological age from them. The interesting output is not the prediction but the error: if the model says 62 and you are 55, that seven-year gap is taken to represent accelerated biological aging.
A long horizon and a second cohort
The analysis used 17,473 participants of the European Prospective Investigation into Cancer and Nutrition, examining associations of plasma proteomic clocks, including organ-specific clocks, with risk factors, 24 incident chronic diseases and all-cause mortality, over up to 28 years of follow-up.
Then, importantly, replication was conducted in the Whitehall II study. Aging clocks have a persistent habit of working in the cohort that produced them and failing elsewhere, so testing in a second population is the part that earns trust.
What the clocks predicted
The signal was broad and in the expected direction. The global age gap was associated with smoking, alcohol consumption, physical inactivity and higher risk of mortality, cardiovascular diseases, dementia and cancers of the liver, upper aero-digestive tract, lung and kidney.
The organ-specific results are more interesting. Lung, kidney and stomach cancers were more strongly associated with related organ-specific age gaps.
That is a genuine finding rather than a generic one. If the clocks were merely detecting that someone was unwell, the global score would have done as well everywhere. Instead a fast-aging kidney predicted kidney cancer better than a fast-aging body did.
The sentence that undercuts the sales pitch
Then comes the line that any honest coverage has to foreground. Predictive performance of proteomic clocks for mortality was comparable to that of classical lifestyle risk factors.
Comparable. Not better. Thousands of proteins, measured on expensive equipment, matched by a short list of questions about smoking, drinking and exercise that a nurse could ask in two minutes.
That is not a failure of the science; predicting mortality as well as the best-established risk factors is a real technical achievement. It is a failure of the marketing, which sells these measures as revealing what your habits conceal.
Where the clocks might still earn their place
Two possibilities survive the comparison. The organ-specific signal is one: a questionnaire cannot tell you which organ is aging fastest, and this study shows the proteins can, at least for some cancers.
The second is measurement honesty. Lifestyle risk factors depend on self-report, and people misreport drinking and activity systematically. A blood measure does not care what you tell it.
Neither of those is demonstrated here as an advantage in practice. They are the reasons to keep looking.
What to conclude
This is observational, so an age gap predicts disease rather than causing it, and closing the gap has not been shown to change anything.
The authors keep their claim modest: proteomic clocks appear promising biomarkers of generalized age-related disease risk.
Promising, replicated, organ-specific, and for now no more informative about your odds of dying than an accurate account of how you live.
People also ask
Should I buy a biological age test?
This study is a reason for caution rather than enthusiasm. The clocks predicted mortality about as well as classical lifestyle risk factors, meaning a questionnaire covering smoking, drinking and activity did roughly the same job as an expensive proteomic panel. Consumer tests also use different methods from these research clocks and are not validated to this standard. Nothing here shows that knowing your score changes your outcome.
What is an 'age gap'?
It is the difference between the age a model predicts from your blood proteins and your actual age. A positive gap means your proteins look older than your birthday suggests. The researchers combined several clocks into a global age gap, and also produced organ-specific versions, so a liver can appear to be aging faster than a kidney in the same person.
Do the organ-specific clocks add anything?
Yes, and this is the study's most useful positive result. Lung, kidney and stomach cancers were more strongly associated with the age gaps of their related organs than with the global score. That specificity suggests the clocks are capturing real organ biology rather than one generic signal of being unwell, which is a meaningful step for the field.
If the clocks match lifestyle questions, are they useless?
Not useless, but not yet additive. Matching a questionnaire is a genuine achievement for a biological measure, and clocks may prove more useful where self-report fails, such as in people who under-report drinking, or for tracking whether an intervention is working. What this study does not support is the claim that a blood test tells you something your habits do not already.
How reliable is the finding?
Reasonably. 17,473 participants with up to 28 years of follow-up is a long horizon, and the replication in a separate cohort is the part that matters most, since aging clocks have a poor track record of transferring between populations. It remains observational, so age gaps predict disease rather than cause it.